球囊封堵TACE治疗肝癌的临床应用研究
Clinical application research of balloon-occluded transcatheter arterial chemoembolization for liver cancer
司同国1
作者信息
- 1. 300060 天津 天津医科大学肿瘤医院(天津市肿瘤医院空港医院,国家恶性肿瘤临床医学研究中心,天津市肿瘤防治重点实验室,天津市恶性肿瘤临床医学研究中心)
- 折叠
摘要
随着相关材料技术的进步,球囊封堵经导管肝动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)技术逐渐应用于临床,成为近年来临床关注的热点.初步结果显示,球囊封堵TACE技术可以提高部分肝癌患者的肿瘤局部控制率,降低病灶复发率,可以应用于常规TACE后复发患者、外科术前桥接治疗,还可以与选择性内照射治疗(selective internal radiation therapy,SIRT)、消融联合应用.但该技术的最佳适用人群、是否增加肝功能损伤、有无特殊并发症等都是临床应用中需要关注的问题,其临床应用的技术条件、预后因素以及如何与其他介入技术联合都值得进一步探讨.
Abstract
With the continuous development of relevant materials,balloon-occluded transcatheter arterial chemoembolization(TACE)has been gradually applied in clinical practice and has become a clinical hot spot of attention in recent years.The results of preliminary studies indicate that balloon-occluded TACE technology can improve the local control rate and reduce the recurrence rate of lesion in some patients with hepatocellular carcinoma(HCC),and this therapeutic technology can be employed in patients who develop recurrence after receiving conventional TACE and in patients who are scheduled to receive preoperative bridging treatment,besides,it can also be adopted together with selective internal irradiation therapy(SIRT)and ablation therapy.However,how to determine the best suitable patients for the technique,whether this technology will increase liver function damage,whether there are special complications,etc.,are all the issues that need to be paid attention to in clinical application.The technical conditions of its clinical application,prognostic factors and how to combine it with other interventional techniques need to be further discussed.
关键词
球囊封堵/化疗栓塞/肝癌Key words
balloon occlusion/chemoembolization/liver cancer引用本文复制引用
出版年
2024
NETL
NSTL
万方数据